Detalhe da pesquisa
1.
A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
Int Wound J
; 21(4): e14882, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606794
2.
A single arm prospective feasibility study evaluating wound closure with a unique wearable device that provides intermittent plantar compression and offloading in the treatment of non-healing diabetic foot ulcers.
Int Wound J
; 20(3): 853-860, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054243
3.
A multicenter, randomized controlled clinical trial evaluating the effects of a novel autologous heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Final analysis.
Int Wound J
; 20(10): 4083-4096, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402533
4.
A multi-centre, single-blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers.
Int Wound J
; 19(4): 791-801, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34418302
5.
Wound repair, safety, and functional outcomes in reconstructive lower extremity foot and ankle surgery using a dehydrated amnion/chorion allograft membrane.
Int Wound J
; 19(8): 2062-2070, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373506
6.
A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis.
Int Wound J
; 19(1): 64-75, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942506
7.
Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers.
Int Wound J
; 19(4): 932-944, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35080127
8.
Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi-centre clinical trial with a microvascular tissue allograft.
Int Wound J
; 19(4): 811-825, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34469077
9.
Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial.
Int Wound J
; 19(5): 1197-1209, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35001559
10.
Complete wound closure following a single topical application of a novel autologous homologous skin construct: first evaluation in an open-label, single-arm feasibility study in diabetic foot ulcers.
Int Wound J
; 17(5): 1366-1375, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32453512
11.
An observational pilot study using a purified reconstituted bilayer matrix to treat non-healing diabetic foot ulcers.
Int Wound J
; 17(4): 966-973, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32266774
12.
An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
Int Wound J
; 15(5): 731-739, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682897
13.
Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
Int Wound J
; 15(6): 950-957, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30019528
14.
A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
Int Wound J
; 14(2): 307-315, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27073000
15.
Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.
Int Wound J
; 13(2): 272-82, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26695998
16.
A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers.
Int Wound J
; 12(6): 724-32, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25424146
17.
A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers.
Int Wound J
; 11(2): 122-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24618401
18.
Prospective, randomized, blinded, comparative study of injectable micronized dehydrated amniotic/chorionic membrane allograft for plantar fasciitis--a feasibility study.
Foot Ankle Int
; 34(10): 1332-9, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23945520
19.
A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers.
Int Wound J
; 10(5): 502-7, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23742102
20.
A Prospective Multicenter Study of a Weekly Application Regimen of Viable Human Amnion Membrane Allograft in the Management of Nonhealing Diabetic Foot Ulcers.
Plast Reconstr Surg Glob Open
; 11(10): e5291, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37811353